The 2011 Leading Animal Health Companies Product Portfolio Analyses
US$ 1,200.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Extensive review of major product lines. Recently introduced products and line extensions. Contains 100 pages
September 2011
100 pages
The 2011 Leading Animal Health Companies Marketing Tactics
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Sales force size in the U.S. and other markets. Promotional tactics. Distribution approaches. Product service and ...
September 2011
38 pages
The 2011 Leading Chemical Companies Facilities and Employees
US$ 1,480.00
... U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international work force size and distribution development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 63 pages
September 2011
63 pages
The 2011 Leading Chemical Companies R&D Expenditures and Major Programs
US$ 2,000.00
... company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 44 pages
September 2011
44 pages
The 2011 Leading Chemical Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 52 pages
September 2011
52 pages
The 2011 Leading Chemical Companies Business Organizations and Senior Management Profiles
US$ 1,480.00
... . Recent acquisitions, divestitures and significant organizational changes. Current organizational structure. Background of key executives. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 125 pages
September 2011
125 pages
The 2011 Leading Food and Beverage Companies Strengths, Weaknesses and Strategic Directions
US$ 1,480.00
For each company, the report provides: Specific business, new product development and marketing objectives and strategies. Strengths and weaknesses. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, ...
September 2011
45 pages
The 2011 Leading Food and Beverage Companies Major Facilities and Employees
US$ 1,480.00
For each company, the report provides: Major administrative, manufacturing, and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. The U.S. and international workforce. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, ...
September 2011
40 pages
The 2011 Leading Food and Beverage Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the report presents: Extensive review of major product lines. Recent new product introductions and line extensions. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. Contains 90 pages
September 2011
90 pages
The 2011 Leading Food and Beverage Companies Marketing Tactics
US$ 1,480.00
For each company, the analysis presents: Sales force in the U.S. and international markets. Distribution strategies. Promotional tactics. Innovative packaging approaches. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. ...
September 2011
65 pages
The 2011 Leading Food and Beverage Companies Collaborations
US$ 1,480.00
For each company, the analysis presents: Major joint ventures, product development and marketing partners. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Cargill, Coca-Cola, ConAgra, Diageo, Kraft, Mars, Nestle, PepsiCo, Tyson, and Unilever. ...
September 2011
45 pages
Emerging Infectious Disease Testing Technologies and Market Applications
US$ 760.00
This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several ...
September 2011
61 pages
The 2011 Global Orthopedics Market Dynamics and Trends
US$ 1,480.00
... categories. In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major ...
September 2011
53 pages
The 2011 Leading Orthopedics Companies Collaborative Arrangements
US$ 1,480.00
... ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 42 ...
September 2011
42 pages
The 2011 Leading Orthopedics Companies Product Portfolio Analyses
US$ 1,400.00
Each company's analysis provides: Review of major product lines. Specifications and features of current products. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 158 pages
September 2011
158 pages
The 2011 Global Pharmaceutical Market Dynamics and Trends
US$ 1,480.00
A 25-page worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for key geographic regions: North America, Europe, Japan, Latin America. Sales ...
September 2011
25 pages
North American Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... , annually updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the North American chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. ...
September 2011
828 pages
European Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the European chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. To assist ...
September 2011
828 pages
Asia Pacific Chemical Market: Strategic Assessments of Leading Suppliers
US$ 11,600.00
... , annually updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the Asia Pacific chemical market. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. To ...
September 2011
828 pages
North American Food and Beverage Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... , capabilities, goals and strategies of the major competitors in the North American Food and Beverage market. The report is designed to provide industry executives ... analyzed in this report include A-B InBev, Cargill, Coca-Cola, Kraft Foods, Mars, Nestlé, PepsiCo, SABMiller, Tyson, and Unilever. The report’s ...
September 2011
600 pages
European Food and Beverage Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... , goals and strategies of the leading players in the European food and beverage market. To help current suppliers realistically assess their financial, ... analysis, data interpretation and insight. To identify the least competitive market niches with significant growth potential. Contains 600 pages and 77 ...
September 2011
600 pages
Asia Pacific Food and Beverage Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... capabilities, goals and strategies of the major competitors in the Asia Pacific Food and Beverage market. The report is designed to provide industry executives with ... analyzed in this report include A-B InBev, Cargill, Coca-Cola, Kraft Foods, Mars, Nestlé, PepsiCo, SABMiller, Tyson, and Unilever. The report’s ...
September 2011
600 pages
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ...
September 2011
1353 pages
North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the North American pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Global CNS Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
Global Infectious Disease Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan ... , goals and strategies of the leading players in the global infectious disease drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
Global Oncology Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Oncology Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Leading Agrochemical Companies Facilities and Employees
US$ 1,480.00
... BASF, Bayer, Dow, DuPont, FMC, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. For each company, the report provides: Administrative, manufacturing and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international workforce size and ...
September 2011
37 pages
The European Orthopedics Market: Strategic Assessments of Leading Suppliers
US$ 7,600.00
The report provides strategic overview of the European orthopedics market, including forecasts for major market segments and product categories. In addition, ... of the major trends with potentially significant impact on the European orthopedics market during the next five years, including industry consolidation ...
September 2011
620 pages
The US Orthopedics Market: Strategic Assessments of Leading Suppliers
US$ 7,600.00
The report provides a strategic overview of the US orthopedics market, including forecasts for major market segments and product categories. In addition, the report presents a concise review of the major trends with potentially significant impact on the US ...
September 2011
620 pages
Biochips: Genosensors, Microarrays, Labs-On-The-Chip
US$ 680.00
Global PDF: US$ 1,900.00 Highlights Biochips, DNA Chips, Genosensors, Microarrays and Labs-on-the-Chip are extensions of biosensor and DNA technologies. ... cost issues continue to complicate their routine use. The report also discusses diagnostic value of biochips, which may not be realized until genetic ...
August 2011
15 pages
DNA Sequencing: Role in Clinical Laboratories
US$ 680.00
... , detection, gene profiling, and expression, polymorphism, screening, protein interaction networks, and others. Sequencing is expected to continue playing a major role in clinical laboratories, e.g., in detecting resistance mutations in viruses and bacteria, especially because of the rising availability of ...
August 2011
15 pages
Genetic Diseases and Pharmacogenomics
US$ 720.00
Global PDF: US$ 1,900.00 This report presents: Overview of the clinical significance and market needs for major genetic diseases Reviews the field of pharmacogenomics Provides listings of companies developing and marketing NAT technologies and products. Contains 75 pages
August 2011
75 pages
Cell Surface Markers: US, Europe, Japan Forecasts by Test, Market Segment and Country
US$ 3,560.00
... are capable of making antibody against a particular antigen, and to sort those cells into separate culture vessels. This permits the screening and ... five years, the main trend in flow cytometry in general, and in cell surface marker analysis specifically, will be further simplification of the sample preparation ...
August 2011
120 pages
NAT Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Analyzers
US$ 680.00
... synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies and compares features of leading NAT analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, Trinity Biotech and other manufacturers. ...
August 2011
20 pages
NAT Applications For Forensic, Paternity and Disease Susceptibility Testing
US$ 680.00
Global PDF: US$ 1,900.00 The report presents: Overview of the clinical significance and market needs for major forensic, paternity, disease susceptibility and other NAT applications. Extensive listings of companies developing and marketing NAT technologies and products. Contains 32 pages
August 2011
32 pages
